Which drug wins? trial pits terlipressin against octreotide for kidney crisis
NCT ID NCT07460908
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two medicines, terlipressin and octreotide, for treating hepatorenal syndrome—a serious kidney complication of advanced liver disease. Sixty adults aged 30 to 70 will receive one of the drugs, and doctors will check kidney function after 48 hours to see which works better. The goal is to find a more effective treatment to improve survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
terlipressin and octreotide
What this could lead to
If one drug works better, it could become the preferred treatment for hepatorenal syndrome, helping more patients recover kidney function quickly.
What could go wrong
This is a small, single-center trial with only 60 participants. Results may not apply to all patients, and neither drug may prove clearly superior.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATORENAL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lahore General Hospital, Lahore
Lahore, Punjab Province, 54000, Pakistan